Orlistat Sandoz

Orlistat, the active ingredient in Orlistat Sandoz, is a Lip Lip presented as a 120mg tablet for oral use. It reduces dietary fat absorption in adults with overweight or obesity. GNH USA supplies Orlistat Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Orlistat Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orlistat is indicated for the management of obesity and related weight‑management pathways. - Overweight adults: Helps achieve clinically significant weight loss when combined with a reduced‑calorie, low‑fat diet. - Obese adults: Supports weight reduction and maintenance as part of a comprehensive weight‑management program. - Overweight adolescents (12 years and older): Assists in weight loss when used with dietary counseling. - Post‑bariatric surgery patients: Aids in managing residual fat absorption. - Individuals with hyperlipidaemia secondary to excess dietary fat: Contributes to lowering fat intake. - Patients with metabolic syndrome: Complements lifestyle interventions to improve weight‑related outcomes.

Orlistat may cause a range of gastrointestinal and systemic reactions.

Common Side Effects: - Oily spotting: Occurs on under‑clothing. - Flatulence with discharge: Often oily or fatty. - Fecal urgency: Increased frequency of bowel movements. - Abdominal cramping: Discomfort in the lower abdomen. - Fat‑soluble vitamin deficiency: Reduced absorption of vitamins A, D, E and K. - Mild headache: Transient head discomfort.

Serious or Rare Side Effects: - Severe hepatic injury: Rare liver dysfunction. - Acute pancreatitis: Inflammation of the pancreas. - Allergic reactions: Rash, pruritus, or anaphylaxis. - Kidney injury: Uncommon renal impairment. - Persistent diarrhea: Ongoing watery stools. - Severe malabsorption: Marked nutrient deficiencies.

Orlistat should be used with careful consideration of dietary fat intake and patient education.

- Monitor dietary fat: Advise the     - Assess   - Evaluate  - Counsel  - Store  - Store at below below   test  t  t  t  t  t -   -  t -  -  -  -  -  -  -  -  -  -  t -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  t -  t -  -  d -  d -  -  d -  -  t g -  -  t -  -  t -  -  - """

The   

    t  t

g  t """""  ""  ""